iQtech Raises Seed Funding for XR Medical Training Platform

Doha, Qatar – Healthtech innovator iQtech has successfully closed its inaugural funding round, securing investment from European assessment technology firm Selexi and deep-tech partner Yuniro. This capital infusion is earmarked to accelerate the development and deployment of its advanced extended reality (XR) platform designed to revolutionize medical education and training.

Founded in 2025 by Nassim Davide Sidaoui, iQtech is at the forefront of integrating immersive virtual reality (VR) with artificial intelligence (AI) to create sophisticated simulation environments. Their flagship product, EsculapioVR, aims to provide a more effective and engaging method for training healthcare professionals, moving beyond traditional learning paradigms. The platform's AI-driven evaluation tools offer objective performance metrics, a critical advancement in ensuring competency and standardizing medical education.

The strategic backing from Selexi, a recognized leader in assessment technologies, and Yuniro, a specialist in deep-tech solutions, underscores the significant potential of iQtech's technology. This partnership is expected to bolster iQtech's product development roadmap, enhance its technical infrastructure, and facilitate expansion into new markets. The company is particularly focused on scaling its operations across the MENA region, leveraging the growing demand for advanced training solutions.

The global market for medical simulation is experiencing robust growth, driven by the need for cost-effective, risk-free training environments and the increasing adoption of digital health technologies. Industry analysts project the market to reach tens of billions of dollars within the next five years, fueled by advancements in VR/AR hardware and AI capabilities. iQtech's XR platform is well-positioned to capture a significant share of this expanding market.

Beyond healthcare, iQtech's versatile XR technology has potential applications in other high-stakes training sectors, including civil aviation and military operations. The ability to create realistic, customizable simulations for complex scenarios offers substantial value in improving preparedness and reducing training costs across these industries. This diversification strategy broadens the company's addressable market and revenue streams.

This seed funding marks a pivotal moment for iQtech, enabling it to transition from development to broader market penetration. The company's focus on combining cutting-edge XR technology with AI-powered analytics addresses a clear need for more effective and measurable training solutions. The successful closure of this round signals strong investor confidence in iQtech's vision and its capacity to disrupt traditional training methodologies in critical sectors.